• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Did we really get an OMNI channel survey…

anonymous

Guest
Asking us what our customers like best? Once you lay us all off ask your inside sales force to find out what they like best when they slam the phones down on them. Brilliant strategic move when we know how hard it was to connect with these offices during COVID when we had relationships. Good luck to ya
 




Asking us what our customers like best? Once you lay us all off ask your inside sales force to find out what they like best when they slam the phones down on them. Brilliant strategic move when we know how hard it was to connect with these offices during COVID when we had relationships. Good luck to ya
Justifying their jobs even though half of them are in interim positions